J9281Mitomycin instillation

Published CMS Medicare Part B payment-limit context for J9281, with recent quarterly history and calculated package-level strength context from the CMS crosswalk.

CMS payment limit

$329.937

per 1 MG · Medicare Part B

Up 2.1%from $323.171 in 2026-Q2

Current quarter: 2026-Q3FinalEffective July 1, 2026
Billing unit: 1 MG

Payment limit over time

$333.1003$304.1787

2024-Q4: $307.342; 2025-Q1: $311.356; 2025-Q2: $312.995; 2025-Q3: $317.421; 2025-Q4: $318.531; 2026-Q1: $323.905; 2026-Q2: $323.171; 2026-Q3: $329.937

No current FDA shortage matchThe latest completed FDA data has no affected record matching the Mitomycin ingredient family (FDA data as of August 20, 2026).

Email me when FDA shortage status changes

Jelmyto

Package figures are calculated from the CMS per-unit payment limit × billable units per package; they are not CMS-published package-level payment limits.

Other Mitomycin presentations

2 other CMS codes

Source-linked same ingredient-family context, not recommendations, substitutes, or clinical or billing equivalence.

Swipe to see all columns

HCPCS	CMS description	Current quarter 2026-Q3	Prior quarter 2026-Q2	Change	NDCs	View history
J9280	Mitomycin injection	$34.107 per 5 MG	$28.459 per 5 MG	Up 19.8%
J9282	Mitomycin intravesical inst	$274.342 per 1 MG	$278.332 per 1 MG	Down 1.4%

Put another code on your radar.

Browse the CMS directory for published payment-limit context across drugs, NDCs, and source-backed HCPCS Level II drug codes.

Explore CMS codes